Congressional Committee Wants Feds To Go After Cannabis Product Manufacturers Making Unlawful Health Claims
The House Appropriations Committee approved a spending bill with an attached report expressing concerns about cannabis-derived products making unlawful health claims and urging federal enforcement action against manufacturers. The report cites a proliferation of such products posing potential health risks while separately supporting psychedelics research.
Filed under Federal Action in THC Minnesota's coverage of Minnesota's cannabis and hemp market.
Mentioned
Source Attribution
This summary was compiled from information published by Marijuana Moment. All facts and statements reflect the original source material. For complete details, refer to the original publication.
View Original Source →Related Updates
Congressional Committee Directs DEA To Crack Down On Unregulated Cannabis Products That ‘Threaten Consumer Safety’
Congressional Committee Directs Feds To Keep Testing Truck Drivers For Marijuana, Regardless Of Trump’s Rescheduling Move
Feds sued over Medicare cannabis product coverage (Newsletter: April 1, 2026)
Ellison and other AGs push for ban on ‘intoxicating hemp-derived’ THC products
White House Raises Alarm About ‘High-Potency’ Marijuana And Its Marketing In New National Drug Strategy
It’s not just THC gummies and drinks – CBD products on federal hit list, too
Stay current on Minnesota cannabis
Browse more federal action updates, the full news feed, or the Minnesota cannabis timeline. Compare products across licensed dispensaries and read our consumer guides.